Composition of M-CSF conjugated to cytotoxic agents and a method

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530402, 530403, 530404, 530405, 424 851, 424 8591, 514 2, 514 8, A61K 3702

Patent

active

050845560

ABSTRACT:
A composition and method for treating cancers characterized by over-expression of the c-fms proto-oncogene/M-CSF receptor protein are provided. The composition involves a M-CSF polypeptide cross-linked to a cytotoxic agent capable of crossing into the cytoplasm of the cell bearing the receptor and killing the cell.

REFERENCES:
patent: 4504586 (1985-03-01), Nicolson
patent: 4545985 (1985-10-01), Pashan et al.
patent: 4675382 (1987-06-01), Murphy
patent: 4933288 (1990-06-01), Greenfield
Bertelmez et al., J. Cell. Physiol., 122, 1985, pp. 362-378.
Granelli-Piperno et al., J. Exp. Med. 163, 1986, pp. 922-937.
Olsnes et al., Pharma Ther., 15, 1982, pp. 355-379.
Clark et al., Science 236, 1987, pp. 1229-1237.
Marimato et al., J. Immunol 131, 1983, pp. 1726-1764.
Metcalf, Blood 67(2), 1986, pp. 257-267.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Composition of M-CSF conjugated to cytotoxic agents and a method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition of M-CSF conjugated to cytotoxic agents and a method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition of M-CSF conjugated to cytotoxic agents and a method will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1862093

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.